He built a men's cosmetics brand on Dragons' Den. The DMs he received afterwards changed everything.
JAAQ wants to be the infrastructure layer between "I think something's wrong" and actually getting help. Bupa's already embedded it for 1.5 million lives.
JAAQ · London · Mental Health / Digital Health Raised £13M ($17.3M) Series A · Investors Meridian Health Ventures, Fuel Ventures, Guinness Ventures, Bolt Angels Team ~24 · Founded May 2021 · Total raised £13M
Danny Gray was bullied as a teenager. It triggered Body Dysmorphic Disorder — a condition where the sufferer becomes consumed by perceived flaws in their appearance that others can barely see. Gray channelled that experience into War Paint for Men, the world’s first cosmetics brand specifically for men, which he successfully pitched on BBC Dragons’ Den and built into a real business with backing from Peter Jones and Tej Lalvani.
But something unexpected happened. As War Paint grew and Gray spoke publicly about his mental health, the messages started arriving. Not about cosmetics. About anxiety. About depression. About feeling like something was wrong and not knowing who to ask. People weren’t looking for a therapist — they hadn’t got that far. They had a question and nowhere to take it.
That gap between having a question and finding an answer became JAAQ.
The name stands for “Just Ask A Question.” Gray incorporated JAAQ Limited as a not-for-profit in May 2021 (Companies House #13386837), followed by JAAQ Corporate Limited three months later (#13589848) as the commercial engine. The dual structure persists: the free consumer platform at jaaq.org is funded by commercial revenue from JAAQ at Work, the B2B arm that embeds mental health content into insurer portals, employer intranets, and banking apps.
Gray has now stepped back from day-to-day leadership. The new CEO is Alex Packham, a serial entrepreneur who built ContentCal (a social media management platform) to 3,000+ customers before selling it to Adobe in December 2021. After three years at Adobe leading product integration and making over 60 venture investments through ASTP Ventures, Packham was advising JAAQ’s board before formally taking the CEO role alongside this raise. The transition from passion-driven founder to commercially seasoned operator is deliberate — and tells you where the company is heading.
What JAAQ actually is (and isn’t)
JAAQ is not a therapy platform. It doesn’t connect you with a therapist. It’s not a chatbot pretending to be one. It doesn’t diagnose you or prescribe treatment.
What it is: a clinically governed content library of over 10,000 expert-led video resources spanning 70+ mental health topics — anxiety, depression, ADHD, addiction, neurodiversity, menopause, sleep, burnout, and more. The videos feature licensed clinicians, psychologists, and “advocates” (real people sharing lived experience). You ask a question in plain language, and JAAQ’s AI matches you with relevant pre-recorded video responses. There’s also a 24/7 conversational AI companion that combines chat with video — the company stresses it’s clinically governed with safety guardrails, not a generic chatbot.
The platform explicitly describes itself as pre-clinical: “Think of JAAQ as your friend who gets it — not a professional.” This positioning is strategically important. It places JAAQ outside medical device regulation, avoids the cost and complexity of clinical trials, and serves as a gateway to formal care rather than a replacement for it.
The real product, though, isn’t the consumer experience. It’s the enterprise infrastructure. JAAQ deploys via API, SDK, or embed directly into partners’ existing digital ecosystems. An insurer can plug JAAQ into its member portal. An employer can embed it in the company intranet. A bank can integrate it into its customer app. The platform processes 60,000 requests per hour and claims ISO 27001, ISO 9001 certification, and HIPAA readiness.
This is a content-as-infrastructure play dressed up as a mental health platform. And the clients suggest it’s working.
The clients that matter
JAAQ’s anchor enterprise client is Bupa. The partnership, which launched in 2022, covers 1.5 million eligible lives through Bupa’s corporate healthcare offering. JAAQ has served over 250,000 answers and 575,000 minutes of content to Bupa users. One unnamed insurer consumed 1.2 million minutes of content and reported deflecting the equivalent of 12 full-time customer service roles.
NatWest deployed JAAQ across its workforce in late 2022. Nationwide Building Society achieved 35% activation across 18,000 employees. Workday and adidas are also named clients. One large UK bank reportedly saved £896,000 through the integration. The company also operates JAAQ Coffee — physical coffee shop spaces in partnership with Genuine Dining Company that integrate mental health conversations into the workplace, with plans for 20 London locations.
The B2B arm generated over £2 million in revenue in under one year, according to the company’s 2024 UK Startup Awards filing. JAAQ won Health and Wellbeing StartUp of the Year at those awards.
JAAQ positions itself as complementary to Employee Assistance Programmes, not a replacement. The pitch to employers and insurers is straightforward: most people don’t use their EAP because they don’t think their problem is “serious enough” to call a helpline. JAAQ catches them earlier — at the moment they first wonder whether something is wrong — and either resolves the question through content or routes them toward professional support.
The investors
Meridian Health Ventures is the most strategically significant backer. Originally founded as KHP Ventures in 2021 and anchored by Guy’s & St Thomas’ NHS Foundation Trust and King’s College Hospital, Meridian runs what it describes as the first NHS-anchored venture fund. Its LP base includes University College London Hospitals, Cedars-Sinai Medical Center, General Catalyst, and the Wellcome Trust. In October 2024, Meridian launched Europe’s first dedicated mental health tech fund — the Innovations in Mental Health Fund — with the Wellcome Trust as anchor investor, in partnership with South London and Maudsley NHS Foundation Trust. Dr Pooja Sikka, a Meridian partner, joined JAAQ’s board. Meridian’s portfolio companies deploy across 100+ NHS Trusts, and its transatlantic fund structure (with Cedars-Sinai as an LP) gives JAAQ a bridge into the US healthcare system.
Fuel Ventures, founded by Mark Pearson (who built and sold MyVoucherCodes for a reported £55 million and was the first investor in UK unicorn Paddle), manages approximately £400 million across 195+ portfolio companies. Partner Shiv Patel led the JAAQ relationship and confirmed a prior connection with CEO Packham — likely from ContentCal or his angel portfolio. This is Fuel’s second appearance in our newsletter after leading Flexzo AI’s round in Edition 13.
Guinness Ventures is the venture arm of Guinness Global Investors (~£8 billion AUM), founded by Tim Guinness — yes, a descendant of the brewing dynasty. Led by CEO Shane Gallwey (ex-HSBC Investment Bank), Guinness Ventures specialises in Series A EIS funding for UK scale-ups, with £340 million+ invested in 200+ companies since 2010. Portfolio highlights include Cera Care (home healthcare, £250M+ revenue), Doctify, and Pasta Evangelists (exited to Barilla).
Bolt Angels, founded by Steve Bolton in 2020, is an angel syndicate with 100+ limited partners and a network of 1,000+ high-net-worth investors. JAAQ is described on Bolt Angels’ website as their flagship investment.
The journey so far
May 2021 — Danny Gray incorporates JAAQ Limited as a not-for-profit. JAAQ Corporate Limited follows in August.
2021-2022 — Free consumer platform launches at jaaq.org with a growing library of expert-led mental health video content.
2022 — Bupa partnership launches, embedding JAAQ into corporate healthcare for 1.5 million eligible lives. NatWest deploys JAAQ for its workforce.
2024 — JAAQ wins Health and Wellbeing StartUp of the Year at the UK Startup Awards. B2B revenue exceeds £2 million in under a year. Alex Packham begins advisory role.
March 2026 — £13 million Series A. Alex Packham formally appointed CEO. Tolga Hassan joins as an advisor (he’s also CFO at Immutrin — a small-world moment in UK healthtech). US expansion announced.
The competition
Digital mental health in the UK is crowded and increasingly well-funded. But the competitive landscape segments clearly, and JAAQ has found whitespace between the categories.
Workplace therapy platforms — Unmind ($90M+ raised, 2.5 million employees covered), Oliva Health, and Spill offer direct therapy, coaching, or self-guided therapeutic tools to employers. They’re clinical interventions sold to HR teams.
NHS clinical services — Kooth (publicly listed, government-funded youth mental health), Healios (virtual ADHD/autism assessments), and ieso Digital Health ($89M raised, acquired by Mindler) deliver formal NHS-commissioned treatment.
AI clinical tools — Wysa (4.5M+ users, FDA Breakthrough Device designation), Limbic (used in 45% of NHS Talking Therapies, Class IIa medical device), and Big Health ($100M+ raised, NICE-recommended digital therapeutics) lead on clinical evidence and regulatory approvals.
JAAQ sits below all of these in the care pathway. It’s not therapy, it’s not diagnosis, and it’s not a regulated medical device. Its competitive advantage is architectural: instead of building a standalone product that users download or clinicians prescribe, JAAQ embeds into existing digital environments as an infrastructure layer. The 10,000-video content library featuring real humans is a unique asset — harder to replicate than an AI chatbot and more engaging than a self-help article.
The insurance channel is genuinely under-explored by competitors. Most digital mental health companies sell to employers or the NHS. Selling to insurers — who have massive customer bases and a financial incentive to reduce claims — is a different go-to-market motion that JAAQ appears to have cracked with Bupa.
Our take
JAAQ’s founding story is compelling. A founder with lived experience of mental health challenges, who built a successful consumer brand and discovered the real demand was for something else entirely. The insight — that most people’s mental health journey begins with a question, not a crisis — rings true. And the B2B pivot from free consumer content to enterprise infrastructure is exactly the kind of strategic evolution that turns a well-intentioned project into a scalable business.
The Bupa partnership is the headline metric. When the UK’s largest private health insurer embeds your product for 1.5 million lives, that’s genuine enterprise validation. The NatWest, Nationwide, and Workday deployments add depth. And Meridian Health Ventures — with its NHS Trust anchor LPs and dedicated mental health fund — brings both credibility and distribution pathways that money alone can’t buy.
The honest questions centre on clinical evidence and competitive defensibility. JAAQ explicitly positions itself as pre-clinical, which keeps it out of the regulatory thicket that constrains competitors. But enterprise buyers — particularly in healthcare — are increasingly demanding clinical outcomes data, not just engagement metrics. Minutes consumed and calls deflected are compelling for a CFO but less persuasive for a Chief Medical Officer. As Unmind, Wysa, and Limbic stack up peer-reviewed evidence and regulatory designations, JAAQ may face pressure to demonstrate that its content actually improves mental health outcomes rather than simply fielding questions.
The content library itself is a genuine moat — 10,000 clinically governed videos from real clinicians and advocates aren’t easily replicated — but it’s also a cost centre that needs continuous investment. And the “pre-clinical” label is a double-edged sword: it unlocks speed and simplicity but may limit JAAQ’s ceiling in markets where clinical evidence gates procurement decisions.
The CEO transition from Danny Gray to Alex Packham is the clearest signal of where this company is heading. Packham built and sold a SaaS company to Adobe. He knows enterprise distribution, international expansion, and what it takes to turn a UK startup into something bigger. If JAAQ can pair its unique content asset and insurer distribution channel with enough clinical evidence to satisfy enterprise procurement, the platform-as-infrastructure model could scale far beyond the UK.
Poor mental health costs UK employers £51 billion annually, according to Deloitte. Over two million people sit on NHS mental health waiting lists. The gap between “I think something’s wrong” and actually getting help is enormous. JAAQ is betting that the answer isn’t more therapists — it’s a better front door.
What we’d ask the founders
The questions this research couldn’t answer:
The B2B arm generated £2M+ in revenue in under a year. What does the run rate look like now, and how many enterprise clients are paying? What’s the average contract value?
Bupa is the anchor client with 1.5 million eligible lives. What’s the actual utilisation rate? There’s a big difference between “eligible” and “active.” How many of those 1.5 million have actually used JAAQ?
You position JAAQ as pre-clinical — “your friend who gets it, not a professional.” But enterprise healthcare buyers increasingly want clinical outcomes evidence. Do you plan to commission clinical studies, and if not, how do you respond when procurement committees ask for peer-reviewed efficacy data?
The consumer app appears to have been deprecated and the free platform seems secondary to B2B. Is the not-for-profit entity (JAAQ Limited) still operationally active, and does the dual-structure create any governance complexity as you scale?
Alex, you sold ContentCal to Adobe and made 60+ angel investments. What specifically about JAAQ made you want to go back to being a full-time operator rather than staying on the investor side?
If you enjoyed this, the most helpful thing you can do is share it with one person who’d find it interesting.